Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

Angiogenesis has been regarded as essential for tumor growth and progression. Studies of many human tumors, however, suggest that their microcirculation may be provided by nonsprouting vessels and that a variety of tumors can grow and metastasize without angiogenesis. Vessel co-option, where tumor c...

書目詳細資料
Main Authors:	Donnem, T, Hu, J, Ferguson, M, Adighibe, O, Snell, C, Harris, A, Gatter, K, Pezzella, F
格式:	Journal article
語言:	English
出版:	2013

相似書籍

Non-angiogenic tumours and their influence on cancer biology
由: Donnem, T, et al.
出版: (2018)

Ways of escape: are all tumours angiogenic?
由: Pezzella, F, et al.
出版: (2001)

Vascular co-option in resistance to anti-angiogenic therapy
由: Domenico Ribatti, et al.
出版: (2023-12-01)

Why some tumours trigger neovascularisation and others don’t: the story thus far
由: Adighibe, O, et al.
出版: (2016)

Future options of anti-angiogenic cancer therapy
由: Yihai Cao
出版: (2016-02-01)

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas.
由: Passalidou, E, et al.
出版: (2002)

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas.
由: Passalidou, E, et al.
出版: (2002)

Is nonangiogenesis a novel pathway for cancer progression? A study using 3-dimensional tumour reconstructions.
由: Adighibe, O, et al.
出版: (2006)

Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases.
由: Jubb, A, et al.
出版: (2011)

Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases
由: Jubb, A, et al.
出版: (2011)

Mathematical models of anti-angiogenic therapy and vessel normalisation
由: Hutchinson, L
出版: (2017)

Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases
由: Gwendolyn Haas, et al.
出版: (2021-04-01)

Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution
由: Johannes Robert Fleischer, et al.
出版: (2023-01-01)

Why some tumours trigger neovascularisation and others don’t: the story thus far
由: Omanma Adighibe, et al.
出版: (2016-02-01)

Tumor vessel co-option: The past & the future
由: Anne Cuypers, et al.
出版: (2022-08-01)

Tumor angiogenesis and anti-angiogenic therapy
由: Ziheng Guo, et al.
出版: (2024-09-01)

Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer.
由: Hu, J, et al.
出版: (2005)

Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases.
由: Liu, D, et al.
出版: (2010)

Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma.
由: Stewart, M, et al.
出版: (2002)

Generation of vessel co-option lung metastases mouse models for single-cell isolation of metastases-derived cells and endothelial cells
由: Anne Cuypers, et al.
出版: (2022-12-01)

Trends and Challenges in Tumor Anti-Angiogenic Therapies
由: József Jászai, et al.
出版: (2019-09-01)

Anti-tumor and Anti-angiogenic Ergosterols from Ganoderma lucidum
由: Shaodan Chen, et al.
出版: (2017-10-01)

Tumor vessel co-option probed by single-cell analysis
由: Laure-Anne Teuwen, et al.
出版: (2021-06-01)

JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues.
由: Adighibe, O, et al.
出版: (2014)

Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas.
由: Sivridis, E, et al.
出版: (2002)

Anti-Tumoral and Anti-Angiogenic Effects of Low-Diluted Phenacetinum on Melanoma
由: Camille Fuselier, et al.
出版: (2021-03-01)

Vascular Co-Option and Other Alternative Modalities of Growth of Tumor Vasculature in Glioblastoma
由: Domenico Ribatti, et al.
出版: (2022-03-01)

Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
由: Giatromanolaki, A, et al.
出版: (2001)

Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation
由: Chao-Nan Qian, et al.
出版: (2016-01-01)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
由: Zhen-Ling Liu, et al.
出版: (2023-05-01)

Resistance Mechanisms of the Metastatic Tumor Microenvironment to Anti-Angiogenic Therapy
由: Lars M. Schiffmann, et al.
出版: (2022-05-01)

Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors
由: Tian Yufeng, et al.
出版: (2010-06-01)

The distribution of lymphatic vessels in lymphomas compared with reactive lymphadenopathy.
由: Pillai, G, et al.
出版: (2003)

Differential action of pro-angiogenic and anti-angiogenic components of Danhong injection in ischemic vascular disease or tumor models
由: Shuang He, et al.
出版: (2022-01-01)

Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases
由: Dipti Vijayan, et al.
出版: (2017-05-01)

Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti‐angiogenic therapy
由: Mouadh Nefiss, et al.
出版: (2022-11-01)

The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study.
由: Stewart, M, et al.
出版: (2003)

Editorial for the Special Issue “Angiogenic Growth Factors in Tumor Development: Beyond New Blood Vessels Formation”
由: Camilla Palumbo, et al.
出版: (2024-11-01)

Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases
由: Miran Rada, et al.
出版: (2021-08-01)

Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options
由: Steven D. Colquhoun
出版: (2018-06-01)